General Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.
Breast Surgery, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, Shandong, China.
BMJ Open. 2022 Jun 22;12(6):e052373. doi: 10.1136/bmjopen-2021-052373.
Investigative studies report contradictory results of the relationship between serum lipid levels and the risk of colorectal cancer (CRC). We conducted a meta-analysis of prospective published studies to clarify the relationship between serum lipid and CRC risk.
Systematic review and meta-analysis.
PubMed and Embase from inception until December 2020.
We considered prospective cohort and case-control studies that evaluated differences in serum lipid levels with the risk of developing CRC.
Two independent reviewers screened and included the studies using standardised electronic data extraction forms. The relative risks of the studies were combined with random-effect and fixed-effect models and were analysed for heterogeneity, publication bias and sensitivity.
Twenty-four prospective studies, including 4 224 317 individuals with 29 499 CRC cases, were included in the meta-analysis. The total pooled risk ratio (RR) for high vs low concentrations of triglyceride (TG) concentrations was reported at 1.21 (95% CI 1.09 to 1.34; I=46.8%), total cholesterol (TC) was at 1.15 (95% CI 1.08 to 1.22; I=36.8%), high-density lipoprotein cholesterol (HDL-C) was 0.86 (95% CI 0.77 to 0.97; I=28.8%) and low-density lipoprotein cholesterol (LDL-C) was observed at 1.03 (95% CI 0.75 to 1.41; I=69.4%).
This meta-analysis shows that high levels of serum TG and TC are positively correlated with the incidence rate of CRC, while high levels of serum HDL-C are negatively correlated with CRC incidence rate. Furthermore, no association was found between LDL-C and the risk of developing CRC. Nevertheless, the heterogeneity brought about by comparative methods, demographic differences and pathological differences between the research subjects limits the effectiveness of the overall pooled results.
研究报告显示,血清脂质水平与结直肠癌(CRC)风险之间的关系存在矛盾。我们对已发表的前瞻性研究进行了荟萃分析,以阐明血清脂质与 CRC 风险之间的关系。
系统综述和荟萃分析。
从建库到 2020 年 12 月,PubMed 和 Embase。
我们考虑了评估血清脂质水平与 CRC 发病风险差异的前瞻性队列研究和病例对照研究。
两名独立的审查员使用标准化的电子数据提取表筛选并纳入研究。使用随机效应和固定效应模型合并研究的相对风险,并对异质性、发表偏倚和敏感性进行分析。
荟萃分析纳入了 24 项前瞻性研究,共包括 4224317 名个体和 29499 例 CRC 病例。汇总的高 vs 低甘油三酯(TG)浓度的总风险比(RR)为 1.21(95%CI 1.09 至 1.34;I=46.8%),总胆固醇(TC)为 1.15(95%CI 1.08 至 1.22;I=36.8%),高密度脂蛋白胆固醇(HDL-C)为 0.86(95%CI 0.77 至 0.97;I=28.8%),低密度脂蛋白胆固醇(LDL-C)为 1.03(95%CI 0.75 至 1.41;I=69.4%)。
这项荟萃分析表明,血清 TG 和 TC 水平升高与 CRC 的发病率呈正相关,而血清 HDL-C 水平升高与 CRC 的发病率呈负相关。此外,LDL-C 与 CRC 发病风险之间没有关联。然而,由于比较方法、研究对象的人口统计学差异和病理学差异带来的异质性,限制了总体汇总结果的有效性。